May 7, 2018 / 6:35 AM / a month ago

BRIEF-Promore Pharma: PRP Will Finance Development Of PXL01

* PROMORE PHARMA OUT-LICENSES PXL01 FOR SPINAL SURGERY TO PHARMARESEARCH PRODUCTS LTD

* PRP WILL FINANCE DEVELOPMENT OF PXL01 FOR USE TO PREVENT FIBROSIS AFTER SPINAL SURGERY

* PRP RECEIVED A GLOBAL COMMERCIAL LICENSE OF PXL01 FOR USE IN THIS INDICATION. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below